炎症性障害の処置のためのヒダントイン誘導体

Japanese Patent JP2009523796

A

This invention relates to compounds of the Formula (I): or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF-α or combinations thereof.

Rabbie, Brian Jay.
Kozlowski, Joseph A.
Butterfly, quayway
Ton, phosphorus
You, Wen Shen
Wong, Michael K. See.
Shanker, Bander Pale Bee.
See, Nen-Yang
Sidiki, M. Ashad
Rosner, Christine Yi.
Dai, Chao Yang
Popovich-Muller, Janeta
Gili Jabalabhan, Vinay M.
Lee dance
Rizbi, Radia
Chen, Ray
Yang, Dee Yi
Robert Felts
Kim, Sung-Hyun

JP2008551310A

June 25, 2009

January 16, 2007

Click for automatic bibliography generation  

Schering Corporation

C07D401/06; A61K31/4178; A61K31/4184; A61K31/4192; A61K31/423; A61K31/427; A61K31/428; A61K31/437; A61K31/4375; A61K31/4436; A61K31/4439; A61K31/4709; A61K31/4725; A61K31/497; A61K31/498; A61K31/501; A61K31/506; A61K31/517; A61K31/519; A61K31/5377; A61K31/541; A61P1/02; A61P1/04; A61P1/14; A61P1/16; A61P3/10; A61P7/00; A61P7/02; A61P7/04; A61P9/00; A61P9/04; A61P9/08; A61P9/10; A61P11/00; A61P11/02; A61P11/06; A61P13/12; A61P17/00; A61P17/06; A61P19/02; A61P19/10; A61P21/00; A61P25/00; A61P25/02; A61P25/32; A61P27/02; A61P27/06; A61P29/00; A61P29/02; A61P31/00; A61P31/04; A61P31/12; A61P33/06; A61P35/00; A61P35/04; A61P37/02; A61P37/04; A61P37/06; A61P37/08; A61P43/00; C07D401/14; C07D403/06; C07D403/14; C07D405/14; C07D409/14; C07D413/00; C07D413/14; C07D417/14; C07D471/04; C07D487/04

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: 炎症性障害の処置のためのヒダントイン化合物

Next Patent: 炎症性障害の処置のためのヒダントイン化合物